Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Marinus Pharmaceuticals Inc fell by 119.98m. Cash Flow from Financing totalled 26.63m or 85.92% of revenues. In addition the company used 118.00m for operations while cash used for investing totalled 28.61m.
Cash flow per share | -2.65 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.8614 |
---|---|
Tangible book value per share | -0.8614 |
More ▼
Balance sheet in USDView more
Current ratio | 2.28 |
---|---|
Quick ratio | 2.15 |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 6.10 |
More ▼